Literature DB >> 8573142

Analysis of p16INK4a and its interaction with CDK4.

R Yang1, M Serrano, J Slater, E Leung, H P Koeffler.   

Abstract

The interaction between cyclin-dependent kinase 4 (CDK4) and its inhibitor p16INK4a (p16) was studied by random mutagenesis and yeast two-hybrid system. The gene encoding p16 was mutagenized randomly and the amino acid changes that affect the binding of p16 to CDK4 were identified. Several amino acid residues were shown to be important for the binding and many of these changes occur at residues conserved in all known human p16 family proteins Most of the mutant p16 proteins that failed to bind to CDK4 contained multiple amino acid changes, and these alterations were observed throughout the entire gene with no apparent mutational patterns or hot spots. Some of the mutations that moderately reduced the binding activity severely affected the kinase-inhibitory activity of p16.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8573142     DOI: 10.1006/bbrc.1996.0045

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis.

Authors:  Thea D Tlsty; Yongping G Crawford; Charles R Holst; Colleen A Fordyce; Jianmin Zhang; Kimberly McDermott; Krystyna Kozakiewicz; Mona L Gauthier
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

2.  Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors.

Authors:  Naoki Mori; Rong Yang; Norihiko Kawamata; Carl W Miller; Hideaki Mizoguchi; H Phillip Koeffler
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

3.  Mutation testing in melanoma families: INK4A, CDK4 and INK4D.

Authors:  J A Newton Bishop; M Harland; D C Bennett; V Bataille; A M Goldstein; M A Tucker; B A Ponder; J Cuzick; P Selby; D T Bishop
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

4.  Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers.

Authors:  Zheng Chen; Yingjie Guo; Da Zhao; Quan Zou; Fusheng Yu; Lijun Zhang; Lei Xu
Journal:  Front Cell Dev Biol       Date:  2021-12-23

5.  Simulation of different truncated p16(INK4a) forms and in silico study of interaction with Cdk4.

Authors:  Najmeh Fahham; Mohammad Hossein Ghahremani; Soroush Sardari; Behrouz Vaziri; Seyed Nasser Ostad
Journal:  Cancer Inform       Date:  2008-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.